kabutan

TEIJIN LIMITED(3401) Summary

3401
TSE Prime
TEIJIN LIMITED
1,560.5
JPY
-15.0
(-0.95%)
Mar 13, 3:30 pm JST
9.78
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
0.78
Yield
3.20%
Margin Trading Ratio
8.54
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
1,550.0 JPY 9.73 USD
Previous Close Mar 12
1,575.5 JPY 9.91 USD
High Mar 13, 10:21 am
1,577.0 JPY 9.91 USD
Low Mar 13, 9:00 am
1,549.5 JPY 9.73 USD
Volume
1,146,500
Trading Value
1.79B JPY 0.01B USD
VWAP
1564.46 JPY 9.81 USD
Minimum Trading Value
156,050 JPY 978 USD
Market Cap
0.31T JPY 1.94B USD
Number of Trades
2,257
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
1,882
1-Year High Nov 5, 2025
8,979
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 191,700 2,029,500 10.59
Feb 27, 2026 188,800 2,047,500 10.84
Feb 20, 2026 184,800 2,084,000 11.28
Feb 13, 2026 193,300 2,106,500 10.90
Feb 6, 2026 194,400 2,100,900 10.81
Company Profile
TEIJIN LIMITED is a major synthetic fiber manufacturer, ranking second globally in carbon fiber production. The company's three main pillars are synthetic fibers, chemical products, and pharmaceuticals/medical care. It also has a presence in the healthcare sector.
Sector
Texstiles & Apparels
TEIJIN LIMITED operates in various business segments including materials, fibers & products, healthcare, and IT. In its materials business, the company manufactures and sells high-performance materials such as aramid fibers, resins, and carbon fibers, as well as composite materials. The fibers & products division focuses on the manufacture and sale of fiber products, polyester fibers, and textiles. In healthcare, TEIJIN LIMITED manufactures and sells pharmaceuticals and medical devices, while also providing home healthcare services. The IT business segment offers information system operation, development, and maintenance services, as well as electronic comic distribution. Additionally, the company manufactures and sells battery materials and membranes, and develops, manufactures, and sells regenerative medicine products and implantable medical devices.